TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3980061

Group type: EXPERIMENTAL
Intervention: L-dopa (125 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: L-dopa (125 mg) plus carbidopa (12.5 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Tyrosine load (100 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Meal low in phenylalanine and tyrosine
Number of subjects: 15
Study: 31944082

Group type: EXPERIMENTAL
Intervention: PDA media
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: YMA and MEA media
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Barley and rye grains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oat grains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50% S + 50% C substrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wheat straw (S) with SCG substrate
Number of subjects: 0
Study: 31426299

Group type: EXPERIMENTAL
Intervention: L. plantarum HEAL9 and L. paracasei 8700:2 (probiotic group)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Maltodextrin (placebo group)
Number of subjects: 78
Study: 28260548

Group type: EXPERIMENTAL
Intervention: Flatbreads made with 15% chickpea flour (CPF) and 3% guar gum (GG)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Flatbreads made with 15% chickpea flour (CPF) and 4% guar gum (GG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control flatbreads made with 100% wheat flour
Number of subjects: 56
Study: 26602073

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg plus Ezetimibe 10 mg
Number of subjects: 1873

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873
Study: 23735724

Group type: EXPERIMENTAL
Intervention: Intensive structured monitoring (ISM) with 4-point glycemic profiles performed 3 days/week
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Active control (AC) with 4-point glycemic profiles performed at baseline and at 6 and 12 months
Number of subjects: 1024
Study: 20639269

Group type: EXPERIMENTAL
Intervention: Randomised-response technique (RRT)
Number of subjects: 597

Group type: COMPARATOR
Intervention: Direct questioning
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Randomised-response technique (RRT) with cheating detection
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Lifetime prevalence estimation
Number of subjects: 597
Study: 19797013

Group type: EXPERIMENTAL
Intervention: GnRH agonist (0.1 mg triptorelin administered on day 3 after embryo transfer)
Number of subjects: 180
Study: 17026560

Group type: EXPERIMENTAL
Intervention: Adrenaline injection with detachable snare (group A)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Adrenaline injection alone (group B)
Number of subjects: 159
Study: 12777340

Group type: EXPERIMENTAL
Intervention: Tapering off plus group CBT
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Tapering off alone
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study: 11079673

Group type: EXPERIMENTAL
Intervention: Two-stage transesophageal atrial pacing stress echocardiography (TAPSE)
Number of subjects: 36
Study: 9378207

Group type: EXPERIMENTAL
Intervention: Pancreatic duct injections (10 or more injections) in Group I
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Difficult common bile duct cannulations in Group I
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Overall incidence of pancreatitis in Group I
Number of subjects: 1979
Study: 8260242

Group type: EXPERIMENTAL
Intervention: 24-h psychological training program (P.T.P.)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Waiting list period (Control)
Number of subjects: 72
Study: 3872304

Group type: EXPERIMENTAL
Intervention: Papaverine hydrochloride (1 mg in 10 cc normal saline)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (10 cc normal saline)
Number of subjects: 17
Study: 30453984

Group type: EXPERIMENTAL
Intervention: Externally stented saphenous vein grafts
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonstented saphenous vein grafts
Number of subjects: 30
Study: 28947462

Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT) added to a rehabilitation programme
Number of subjects: 52

Group type: COMPARATOR
Intervention: Rehabilitation programme without KT (no-KT)
Number of subjects: 52
Study: 25082955

Group type: EXPERIMENTAL
Intervention: Balance exercises in front of optokinetic stimuli during weeks 4-8
Number of subjects: 12

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 12
Study: 23219622

Group type: EXPERIMENTAL
Intervention: Posterior stabilized high flexion device
Number of subjects: 93

Group type: COMPARATOR
Intervention: Posterior stabilized standard device
Number of subjects: 93
Study: 22041948

Group type: EXPERIMENTAL
Intervention: Interactive CD-ROM about responding to patients' negative emotions
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (communication lecture)
Number of subjects: 312
Study: 18436153

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 1435

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1435
Study: 16956818

Group type: EXPERIMENTAL
Intervention: 4 mg zoledronic acid iv every 6 months (group A)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 4 mg zoledronic acid iv every 3 months (group B)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo every 3 months (group C)
Number of subjects: 66
Study: 15314993

Group type: EXPERIMENTAL
Intervention: Thiamazole
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 131I
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 10551639

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST) administered 24 hr before transplant and 7-10 days posttransplant
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (no DST)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Blood stored for > or =3 days
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Transfused patients with more class I antigen mismatches
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Overall class II antigen mismatches
Number of subjects: 212
Study: 8722732

Group type: EXPERIMENTAL
Intervention: Heel lift (6 patients)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dynamic insoles (6 patients)
Number of subjects: 12
Study: 1716338

Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 267

Group type: COMPARATOR
Intervention: F-MACHOP
Number of subjects: 267
Study: 6411885

Group type: EXPERIMENTAL
Intervention: Zinc intake at greater than 150 micrograms/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Copper intake at greater than 16 micrograms/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Zinc intake at 438 micrograms/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Copper intake at 63 micrograms/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Zinc intake ranging from 91 to 824 micrograms/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Copper intake ranging from 8 to 92 micrograms/kg/day
Number of subjects: 38
Study: 30550151

Group type: EXPERIMENTAL
Intervention: Patients with distant metastasis (n=37)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Patients without distant metastasis (n=37)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Distant metastasis characteristics
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Factors analyzed
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: AJCC staging and pigment deposition
Number of subjects: 74
Study: 25582800

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy for children (MBCT-C)
Number of subjects: 10
Study: 24670086

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme replacement therapy (PERT) (50,000 IU lipase)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 22527559

Group type: EXPERIMENTAL
Intervention: Vaginal prolapse repair with mesh
Number of subjects: 65

Group type: COMPARATOR
Intervention: Vaginal prolapse repair without mesh
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Vaginal prolapse repair (with or without mesh)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Achieving first goal
Number of subjects: 65
Study: 20064730

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Saphenofemoral ligation and stripping of the great saphenous vein (surgery)
Number of subjects: 121
Study: 17315079

Group type: EXPERIMENTAL
Intervention: Management options for weight loss in Alzheimer's disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural history of weight loss in Alzheimer's disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etiological factors of weight loss in Alzheimer's disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consequences of weight loss in Alzheimer's disease
Number of subjects: 0
Study: 15764622

Group type: EXPERIMENTAL
Intervention: Alternating pressure air mattress (APAM) - Alpha‐X‐Cell, Huntleigh Healthcare, UK
Number of subjects: 447

Group type: COMPARATOR
Intervention: Visco-elastic foam mattress (Tempur, Tempur-World Inc., USA) with turning every 4 hours
Number of subjects: 447
Study: 11882513

Group type: EXPERIMENTAL
Intervention: Low-dose glucose infusion at a mean rate of 6 mg x kg(‐1) x min(‐1)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-dose glucose infusion at a mean rate of 12 mg x kg(‐1) x min(‐1)
Number of subjects: 7
Study: 9878012

Group type: EXPERIMENTAL
Intervention: 125 mg famciclovir
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: 250 mg famciclovir
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: 500 mg famciclovir
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 7626850

Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m2 and Cyclophosphamide 1200 mg/m2
Number of subjects: 105

Group type: COMPARATOR
Intervention: Cisplatin 80 mg/m2 and Cyclophosphamide 900 mg/m2
Number of subjects: 105
Study: 1903370

Group type: EXPERIMENTAL
Intervention: Lecture only
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Lecture and clinical practice
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 85
Study: 6795656

Group type: EXPERIMENTAL
Intervention: Maprotiline (up to 150 mg/day for 2 weeks, then up to 300 mg/day if indicated)
Number of subjects: 28
Study: 31801485

Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 276

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 276
Study: 29089313

Group type: EXPERIMENTAL
Intervention: RADPAD
Number of subjects: 766

Group type: COMPARATOR
Intervention: SHAMPAD
Number of subjects: 766
Study: 25705005

Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-eluting balloon (DEB)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 182
Study: 22803597

Group type: EXPERIMENTAL
Intervention: Atomoxetine 20 mg twice daily
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Atomoxetine 60 mg twice daily
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 21363899

Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 880

Group type: COMPARATOR
Intervention: Conventional ward treatment
Number of subjects: 880
Study: 19140995

Group type: EXPERIMENTAL
Intervention: Testing as the final activity in the skills course (3.5 hours of instruction and training followed by 30 minutes of testing)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control course (4 hours of instruction and training)
Number of subjects: 140
Study: 17543656

Group type: EXPERIMENTAL
Intervention: RSI plus etomidate bolus followed by continuous sedative infusion (ETO group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: RSI plus placebo followed by continuous sedative infusion (placebo group)
Number of subjects: 41
Study: 12737240

Group type: EXPERIMENTAL
Intervention: Mandibular overdenture supported by two endosseous implants with a connecting bar
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional denture
Number of subjects: 102
Study: 10927737

Group type: EXPERIMENTAL
Intervention: Cocoa-bran cereal (25.0 g/d of total dietary fiber)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low-fiber cereal (5.6 g/d of total dietary fiber)
Number of subjects: 25
Study: 8723472

Group type: EXPERIMENTAL
Intervention: Trimethoprim (200 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zidovudine (200 mg), Trimethoprim (200 mg), Dapsone (100 mg)
Number of subjects: 8
Study: 1328362

Group type: EXPERIMENTAL
Intervention: Low-dose angiotensin II infusion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 24
Study: 2865712

Group type: EXPERIMENTAL
Intervention: 4 mg dipipanone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 8 mg dipipanone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 mg dipipanone
Number of subjects: 12
Study: 3312977

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (0.5 mL, 1 mg/mL)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (0.5 mL)
Number of subjects: 37
Study: 31736068

Group type: EXPERIMENTAL
Intervention: AS04‐HPV‐16/18 vaccine (in Arms A and B)
Number of subjects: 4871

Group type: COMPARATOR
Intervention: Control vaccine (in Arms A/B and all Arm C)
Number of subjects: 4871
Study: 30319010

Group type: EXPERIMENTAL
Intervention: Bone cement filling in the right hind femur
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control leg (non-cemented contralateral leg)
Number of subjects: 0
Study: 26582910

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration plus PCI
Number of subjects: 440

Group type: COMPARATOR
Intervention: Standard PCI
Number of subjects: 440
Study: 26333743

Group type: EXPERIMENTAL
Intervention: Basic arthroscopic simulation tasks using a box model
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Inter-rater and intra-rater reliability assessment
Number of subjects: 49
Study: 24097234

Group type: EXPERIMENTAL
Intervention: Universal glove and gown use
Number of subjects: 26180

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 26180
Study: 21496417

Group type: EXPERIMENTAL
Intervention: Hypertensive with moderate and severe OSA group
Number of subjects: 184
Study: 18347489

Group type: EXPERIMENTAL
Intervention: Fast-absorbing catgut suture
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nylon suture
Number of subjects: 47
Study: 16837676

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily
Number of subjects: 10101
Study: 12667722

Group type: EXPERIMENTAL
Intervention: Apomorphine sublingual 4mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11082801

Group type: EXPERIMENTAL
Intervention: 8-week nurse-managed, peer-led smoking cessation intervention including 21 mg nicotine patch therapy for 6 weeks, weekly counseling, and skills training
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group received written self-help materials for smoking cessation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 8-week nurse-managed, peer-led smoking cessation intervention
Number of subjects: 8
Study: 8833712

Group type: EXPERIMENTAL
Intervention: FULL wet suit
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: LONG wet suit
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: SHORT wet suit
Number of subjects: 5

Group type: COMPARATOR
Intervention: Conventional swimming suit (SS)
Number of subjects: 5
Study: 1442591

Group type: EXPERIMENTAL
Intervention: Shock-wave thrombus ablation (1,000 shocks/24 kv)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no shock waves)
Number of subjects: 15
Study: 2931153

Group type: EXPERIMENTAL
Intervention: Physiotherapy and education programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bed rest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early mobilisation
Number of subjects: 0
Study: 29680812

Group type: EXPERIMENTAL
Intervention: Smartphone application used weekly for 12 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care involving regular (approximately 3 monthly) CF outpatient clinic appointments
Number of subjects: 60
Study: 30634207

Group type: EXPERIMENTAL
Intervention: Jiedu Shengji Recipe (JSR), one dose per day for 8 weeks
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group: mixture of dexamethasone, lidocaine, and gentamicin, 10 mL each time before radiation
Number of subjects: 86
Study: 23519913

Group type: COMPARATOR
Intervention: Acidulated phosphate fluoride (APF) gel for 4 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fractional CO(2) laser applied before APF gel (10 mJ, 200 Hz, 10 s)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fractional CO(2) laser applied through APF gel (10 mJ, 200 Hz, 10 s)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 60
Study: 22372591

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate 40 mg every second day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Estradiol valerate 2 mg daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of testosterone undecanoate and estradiol valerate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study: 20451681

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg/day subcutaneously for 14 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 10
Study: 17953787

Group type: EXPERIMENTAL
Intervention: Pro Children intervention (FV curriculum and improved FV availability)
Number of subjects: 1472
Study: 15943872

Group type: EXPERIMENTAL
Intervention: Deep inspiration (DI) induced bronchodilation after constricting the airways with methacholine
Number of subjects: 15
Study: 12477078

Group type: EXPERIMENTAL
Intervention: Dimetindene (H1‐receptor antagonist) plus cimetidine (H2‐receptor antagonist)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dimetindene plus cimetidine
Number of subjects: 17
Study: 10740330

Group type: EXPERIMENTAL
Intervention: goserelin
Number of subjects: 160

Group type: COMPARATOR
Intervention: danazol
Number of subjects: 160
Study: 8893901

Group type: EXPERIMENTAL
Intervention: Single-agent doxorubicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-agent paclitaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of doxorubicin and paclitaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen used by Gianni et al
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of dexrazoxane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin combined with paclitaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carboplatin and paclitaxel
Number of subjects: 0
Study: 1575171

Group type: EXPERIMENTAL
Intervention: Quinapril (20 mg dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 0
Study: 2859819

Group type: EXPERIMENTAL
Intervention: Syrup of ipecac
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Gastric lavage
Number of subjects: 592

Group type: COMPARATOR
Intervention: No gastric emptying procedures
Number of subjects: 592
Study: 31536118

Group type: EXPERIMENTAL
Intervention: Small-for-gestational-age infants
Number of subjects: 316

Group type: COMPARATOR
Intervention: Appropriate-for-gestational-age infants
Number of subjects: 316

Group type: COMPARATOR
Intervention: Positive-pressure ventilation
Number of subjects: 316

Group type: COMPARATOR
Intervention: Patent ductus arteriosus (PDA)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Macronutrient/energy intakes
Number of subjects: 316
Study: 29235076

Group type: EXPERIMENTAL
Intervention: Aerobic/resistance and cognitive dual task (n=28)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aerobic/resistance and computer lessons (n=21)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Stretching exercises and cognitive dual task (n=23)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Stretching exercises and computer lessons (n=18)
Number of subjects: 90
Study: 27005470

Group type: EXPERIMENTAL
Intervention: Specific movement control exercise (SMCE) combined with manual therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: General exercise combined with manual therapy
Number of subjects: 70
Study: 25721344

Group type: EXPERIMENTAL
Intervention: Quiet Eye Training (QET)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional Training (TT)
Number of subjects: 30
Study: 23769990

Group type: EXPERIMENTAL
Intervention: FLU/TBI
Number of subjects: 85

Group type: COMPARATOR
Intervention: TBI
Number of subjects: 85
Study: 20496059

Group type: EXPERIMENTAL
Intervention: Observational practice
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Physical practice
Number of subjects: 36

Group type: COMPARATOR
Intervention: No practice (Control)
Number of subjects: 36
Study: 18293016

Group type: EXPERIMENTAL
Intervention: beta‐hydroxyl beta‐methyl butyrate, glutamine, and arginine (HMB/Arg/Gln)
Number of subjects: 472

Group type: COMPARATOR
Intervention: isonitrogenous, isocaloric control mixture
Number of subjects: 472
Study: 15733808

Group type: EXPERIMENTAL
Intervention: BFI‐K (Korean version of the Brief Fatigue Inventory)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: BFI‐K
Number of subjects: 178
Study: 13680197

Group type: EXPERIMENTAL
Intervention: [18F]FEF
Number of subjects: 5

Group type: COMPARATOR
Intervention: Displacement injection of 0.01 mg/kg of unlabelled flumazenil
Number of subjects: 5
Study: 10608469

Group type: EXPERIMENTAL
Intervention: High salt diet (220 mmol/day)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Low salt diet (20 mmol/day)
Number of subjects: 163
Study: 7723358

Group type: EXPERIMENTAL
Intervention: isradipine 2.5 mg twice daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: atenolol 100 mg daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: isradipine and atenolol (comparison)
Number of subjects: 10